Icard Bradley L, Rubio Edmundo
a Department of Pulmonary, Critical Care, and Sleep Medicine , Carilion Clinic - Virginia Tech Carilion School of Medicine , Roanoke , VA , USA.
Expert Rev Respir Med. 2017 Oct;11(10):807-814. doi: 10.1080/17476348.2017.1359090. Epub 2017 Jul 26.
The management of airway secretions in the mechanically ventilated patient is a routine task throughout all intensive care units. The current treatment strategies are primarily based on anecdotal experiences rather than statistical evidence. Areas covered: This review article evaluates the data from published trials surrounding mucoactive agents and their use in the critically ill patient population. We completed an extensive search through PUBMED and CINAHL via EBSCO, along with the Cochran library to find all trials using mucoactive agents in the critically ill patient population. Expert commentary: Overall, the role of mucoactive agents in the intensive care unit is a field within pulmonary critical care that is in need of evidence-based recommendations. We feel that there is great opportunity for investigators to evaluate different mucoactive therapies in this patient population and to determine their effect on clinical outcomes.
在所有重症监护病房中,对机械通气患者气道分泌物的管理都是一项常规任务。当前的治疗策略主要基于经验而非统计证据。涵盖领域:这篇综述文章评估了已发表试验中有关黏液促排剂及其在危重症患者群体中应用的数据。我们通过EBSCO平台在PUBMED和CINAHL数据库以及Cochrane图书馆进行了广泛检索,以查找所有在危重症患者群体中使用黏液促排剂的试验。专家评论:总体而言,黏液促排剂在重症监护病房中的作用是肺部重症监护领域中一个需要循证推荐的领域。我们认为,研究人员有很大机会评估该患者群体中不同的黏液促排疗法,并确定它们对临床结局的影响。